Legend Biotech Corporation
LEGN
$19.66
-$0.25-1.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 71.85% | -14.66% | -67.74% | 31.12% | -14.17% |
| Total Depreciation and Amortization | 112.87% | 88.89% | 34.33% | 16.52% | 2.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -46.62% | 167.73% | 3,955.47% | 28.51% | 499.79% |
| Change in Net Operating Assets | 15.56% | 36.17% | -612.06% | -307.06% | -324.13% |
| Cash from Operations | 67.45% | 68.95% | 30.41% | -7.90% | -92.58% |
| Capital Expenditure | -107.02% | -245.75% | -102.65% | -15.59% | 19.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.29% | 269.71% | 188.24% | 100.52% | 139.81% |
| Cash from Investing | -0.54% | 244.04% | 183.42% | 95.27% | 137.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,070.01% | -0.45% | 11.00% | -26.71% | -22.40% |
| Issuance of Common Stock | 2,684.34% | -79.15% | -66.15% | -63.44% | 9.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,507.72% | -137.98% | -104.86% | -99.44% | -1.58% |
| Foreign Exchange rate Adjustments | -130.76% | 1,068.91% | 388.52% | 286.07% | 1,100.60% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 522.68% | 144.90% | 162.07% | 64.21% | 106.32% |